Clay Thorp, Director, 10% Owner at Clearside Biomedical, Inc. (CLSD), sold 35,000 shares at $7.02 ($245K) on 2017-11-14, disclosed to the SEC on 2017-11-16.
Open-market sale of $245k CLSD by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.02 | 15,000 | $105K | 43.0% |
| 2 | $6.99 | 15,000 | $105K | 42.8% |
| 3 | $6.99 | 5,000 | $35K | 14.3% |
| Total | $7.00 avg | 35,000 | $245K | 100% |
| Filing → |
| CLSD | BUY | 2022-12-21 | $14K | — | Filing → |
| VIGL | BUY | 2022-05-17 | $165K | — | Filing → |
| VIGL | BUY | 2022-03-28 | $22K | — | Filing → |